NCT02608918View on ClinicalTrials.gov

Taste Properties of HIV Inhibitor

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

January 5, 2016

Primary Completion Date

May 24, 2016

Study Completion Date

May 24, 2016

Conditions

HIV Infections

Interventions

DRUG

BMS-955176

Trial Locations (1)

01801

GSK Investigational Site, Woburn

Sponsors

Lead Sponsor

ViiV Healthcare

All Listed Sponsors

collaborator

Senopsys, LLC

INDUSTRY

lead

ViiV Healthcare

INDUSTRY

NCT02608918 - Taste Properties of HIV Inhibitor | Biotech Hunter | Biotech Hunter